Hybrid single‑photon emission computed tomography‑computed tomography: A review of literature
Article Sidebar
Views | PDF/EPUB Downloads:
65
/ 6
/ 6
Main Article Content
Abstract
The use of hybrid imaging consisting of single-photon emission computed tomography (SPECT) and X-ray transmission computed tomography (CT) scan has the advantage of providing functional and morphologic information for a given lesion or pathology in a single session. Internet search of PubMed and Google Scholar databases was undertaken. Key phrases searched were SPECT-CT and lesion categorization or characterization. Studies considered for review include a comparison of SPECT-CT versus SPECT scintigraphy,
SPECT-CT versus SPECT versus planar scintigraphy, and SPECT-CT in patients with indeterminate lesions on conventional scintigraphy either for benign or malignant conditions. Fusion of functional information obtained from radionuclide imaging with morphologic information obtained from X-ray CT has improved lesion localization, characterization, and observer confidence. It has been shown to change patient management.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
How to Cite
References
1. Buck AK, Nekolla S, Ziegler S, Beer A, Krause BJ, Herrmann K, et al. SPECT/CT. J Nucl Med 2008;49:1305‑19. Erratum in: J Nucl Med 2008; 49:1407.
2. Seo Y, Mari C, Hasegawa BH. Technological development and advances in single‑photon emission computed tomography/computed
tomography. Semin Nucl Med 2008;38:177‑98.
3. Jacene HA, Goetze S, Patel H, Wahl RL, Ziessman HA. Advantages of hybrid SPECT‑CT alone. Open Med Imaging J 2008;2:67‑9.
4. Mariani G, Bruselli L, Kuwert T, Kim EE, Flotats A, Israel O, et al. A review on the clinical uses of SPECT/CT. Eur J Nucl Med Mol Imaging 2010; 37:1959‑85.
5. Horger M, Eschmann SM, Pfannenberg C, Vonthein R, Besenfelder H, Claussen CD, et al. Evaluation of combined transmission and emission tomography for classification of skeletal lesions. AJR Am J Roentgenol 2004;183:655‑61.
6. Römer W, Nömayr A, Uder M, Bautz W, Kuwert T. SPECT‑guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients. J Nucl Med 2006;47:1102‑6.
7. Strobel K, Burger C, Seifert B, Husarik DB, Soyka JD, Hany TF. Characterization of focal bone lesions in the axial skeleton: Performance of planar bone scintigraphy compared with SPECT and SPECT fused with CT. AJR Am J Roentgenol 2007;188:W467‑74.
8. Mohan HK, Gnanasegaran G, Vijayanathan S, Fogelman I. SPECT/CT in imaging foot and ankle pathology‑the demise of other coregistration techniques. Semin Nucl Med 2010;40:41‑51.
9. Langroudi B, Mohan H, Gnanasegaran G, Adamson K, Taylor A, Klinke M, et al. SPECT‑CT in the assessment of bony foot pathology. J Nucl Med 2007;48 Suppl 2:122.
10. Mohan HK, Holker PF, Gnanasegaran G, Vijayanathan S, Sharp D, Langroudi B, et al. The applicability of SPECT‑CT in directing the
management of bony foot and ankle pathology. Eur J Nucl Med Mol Imaging 2007;34:S166.
11. Ndlovu X, George R, Ellmann A, Warwick J. Should SPECT‑CT replace SPECT for the evaluation of equivocal bone scan lesions in patients with underlying malignancies? Nucl Med Commun 2010;31:659‑65.
12. Yunusa GH, Brink A. Assessment of the impact of application of single‑photon emission computed tomography and SPECT‑CT on lesion categorization in bone scintigraphy. S Afr J Radiol 2016;20:a990.
13. Palmedo H, Marx C, EbertA, Kreft B, KoY, Türler A, et al. Whole‑body SPECT/CT for bone scintigraphy: Diagnostic value and effect on
patient management in oncological patients. Eur J Nucl Med Mol Imaging 2014;41:59‑67.
14. Kizu H, Takayama T, Fukuda M, Egawa M, Tsushima H, Yamada M, et al. Fusion of SPECT and multidetector CT images for accurate localization of pelvic sentinel lymph nodes in prostate cancer patients. J Nucl Med Technol 2005;33:78‑82.
15. Zhang WJ, Zheng R, Wu LY, Li XG, Li B, Chen SZ. Clinical application of sentinel lymph node detection to early stage cervical cancer. Ai Zheng 2006;25:224‑8.
16. Andersen JB, Mortensen J, Bech BH, Højgaard L, Borgwardt L. First experiences from Copenhagen with paediatric single photon emission computed tomography/computed tomography. Nucl Med Commun 2011;32:356‑62.
17. Lerman H, Lievshitz G, Zak O, Metser U, Schneebaum S, Even‑Sapir E. Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer. J Nucl Med 2007;48:201‑6.
18. Even‑Sapir E, Lerman H, Lievshitz G, Khafif A, Fliss DM, SchwartzA, et al. Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. J Nucl Med 2003;44:1413‑20.
19. Lerman H, Metser U, Lievshitz G, Sperber F, Shneebaum S, Even‑Sapir E. Lymphoscintigraphic sentinel node identification in patients with breast cancer: The role of SPECT‑CT. Eur J Nucl Med Mol Imaging 2006;33:329‑37.
20. Husarik DB, Steinert HC. Single‑photon emission computed tomography/computed tomographyfor sentinel node mapping in breast cancer. Semin Nucl Med 2007;37:29‑33.
21. Kretschmer L, Altenvoerde G, Meller J, Zutt M, Funke M, Neumann C, et al. Dynamic lymphoscintigraphy and image fusion of SPECT and pelvic CT‑scans allow mapping of aberrant pelvic sentinel lymph nodes in malignant melanoma. Eur J Cancer 2003;39:175‑83.
22. Garcia‑Burillo A, Bilsa IR, Gonzalez O, Zafon C, Sabate M, Castellvi J, et al. SPECT/CT sentinel lymph node identification in papillary thyroid cancer: lymphatic staging and surgical management improvement. Eur J Nucl Med Mol Imaging 2013;40:1645‑55.
23. Wagner A, Schicho K, Glaser C, Zettinig G, Yerit K, Lang S, et al. SPECT‑CT for topographic mapping of sentinel lymph nodes prior to gamma probe‑guided biopsy in head and neck squamous cell carcinoma. J Craniomaxillofac Surg 2004;32:343‑9.
24. Filippi L, Schillaci O. Usefulness of hybrid SPECT/CT in 99mTc‑HMPAO‑labeled leukocyte scintigraphy for bone and joint infections. J Nucl Med 2006;47:1908‑13.
25. Horger M, Eschmann SM, Pfannenberg C, Storek D, Dammann F, Vonthein R, et al. The value of SPET/CT in chronic osteomyelitis. Eur J Nucl Med Mol Imaging 2003;30:1665‑73.
26. Spanu A, Solinas ME, Chessa F, Sanna D, Nuvoli S, Madeddu G. 131I SPECT/CT in the follow‑up of differentiated thyroid carcinoma: Incremental value versus planar imaging. J Nucl Med 2009;50:184‑90.
27. Tharp K, IsraelO, Hausmann J, Bettman L, Martin WH, Daitzchman M, et al. Impact of 131I‑SPECT/CT images obtained with an integrated
system in the follow‑up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging 2004;31:1435‑42.
28. Ruf J, Lehmkuhl L, Bertram H, Sandrock D, Amthauer H, Humplik B, et al. Impact of SPECT and integrated low‑dose CT after radioiodine
therapy on the management of patients with thyroid carcinoma. Nucl Med Commun 2004;25:1177‑82.
29. Krausz Y, Bettman L, Guralnik L, Yosilevsky G, Keidar Z, Bar‑Shalom R, et al. Technetium‑99m‑MIBI SPECT/CT in primary hyperparathyroidism. World J Surg 2006;30:76‑83.
30. Serra A, Bolasco P, Satta L, Nicolosi A, Uccheddu A, Piga M. Role of SPECT/CT in the preoperative assessment of hyperparathyroid patients. Radiol Med 2006;111:999‑1008.
31. Hillel PG, van Beek EJ, Taylor C, Lorenz E, Bax ND, Prakash V, et al.The clinical impact of a combined gamma camera/CT imaging system
on somatostatin receptor imaging of neuroendocrine tumours. Clin Radiol 2006;61:579‑87.
32. Castaldi P, Rufini V, Treglia G, Bruno I, Perotti G, Stifano G, et al. Impact of 111In‑DTPA‑octreotide SPECT/CT fusion images in the management of neuroendocrine tumours. Radiol Med 2008;113:1056‑67.
33. Krausz Y, Keidar Z, Kogan I, Even‑Sapir E, Bar‑Shalom R, Engel A, et al. SPECT/CT hybrid imaging with 111In‑pentetreotide in assessment of neuroendocrine tumours. Clin Endocrinol (Oxf) 2003;59:565‑73.
34. Pfannenberg AC, Eschmann SM, Horger M, Lamberts R, Vonthein R, Claussen CD, et al. Benefit of anatomical‑functional image fusion in
the diagnostic work‑up of neuroendocrine neoplasms. Eur J Nucl Med Mol Imaging 2003;30:835‑43.
35. Rozovsky K, Koplewitz BZ, Krausz Y, Revel‑Vilk S, Weintraub M, Chisin R, et al. Added value of SPECT/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma. AJR Am J Roentgenol 2008;190:1085‑90.
36. Schillaci O, Danieli R, Manni C, Capoccetti F, Simonetti G. Technetium‑99m‑labelled red blood cell imaging in the diagnosis of hepatic haemangiomas: The role of SPECT/CT with a hybrid camera. Eur J Nucl Med Mol Imaging 2004;31:1011‑5.
37. Schillaci O, Spanu A, Tagliabue L, Filippi L, Danieli R, Palumbo B, et al. SPECT/CT with a hybrid imaging system in the study of lower gastrointestinal bleeding with technetium‑99m red blood cells. Q J Nucl Med Mol Imaging 2009;53:281‑9.
38. Sodee DB, Sodee AE, Bakale G. Synergistic value of single‑photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer. Semin Nucl Med 2007;37:17‑28.
39. Jana S, Blaufox MD. Nuclear medicine studies of the prostate, testes, and bladder. Semin Nucl Med 2006;36:51‑72.